IFNAR2 Antikörper (AA 27-243) (HRP)
Kurzübersicht für IFNAR2 Antikörper (AA 27-243) (HRP) (ABIN7156583)
Target
Alle IFNAR2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 27-243
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Interferon alpha/beta receptor 2 protein (27-243AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- IFNAR2 (Interferon alpha/beta Receptor 2 (IFNAR2))
-
Andere Bezeichnung
- IFNAR2
-
Hintergrund
-
Background: Associates with IFNAR1 to form the type I interferon receptor. Receptor for interferons alpha and beta. Involved in IFN-mediated STAT1, STAT2 and STAT3 activation. Isoform 1 and isoform 2 are directly involved in signal transduction due to their association with the TYR kinase, JAK1. Isoform 3 is a potent inhibitor of type I IFN receptor activity.
Aliases: Human interferon alpha/beta receptor antibody, IFN alpha REC antibody, IFN R antibody, IFN-a/R2 antibody, IFN-a/R antibody, IFN-alpha binding protein antibody, IFN-alpha/beta receptor 2 antibody, IFN-R-2 antibody, IFNABR antibody, IFNAR2 antibody, IFNARB antibody, IFNR antibody, INAR2_HUMAN antibody, Interferon (alpha beta and omega) receptor 2 antibody, Interferon alpha binding protein antibody, Interferon alpha/beta receptor 2 antibody, Interferon alpha/beta receptor beta chain antibody, Type I interferon receptor 2 antibody, Type I interferon receptor antibody
-
UniProt
- P48551
-
Pathways
- JAK-STAT Signalweg, Hepatitis C
Target
-